Myocardial Infarction

Progress has been made in research on innovative treatments, mechanical and pharmacological approaches, and repair/regenerative cellular therapy to treat irreversible cardiovascular illnesses such as myocardial infarction. In cellular therapy research, new cellular types are being researched. Although the therapeutic effects of cell therapy are still limited, clinical trial results are encouraging.

This advancement is being aided by advances in stem cell paracrine activity, the use of growth factors, miRNA, and novel biomaterials. In the near future, these therapies should become commonplace in clinical practise.

Related Conference of Cardiology